These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 23915164)

  • 1. Causes of SLIT discontinuation and strategies to improve the adherence: a pragmatic approach.
    Savi E; Peveri S; Senna G; Passalacqua G
    Allergy; 2013 Sep; 68(9):1193-5. PubMed ID: 23915164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term comparison of sublingual immunotherapy vs inhaled budesonide in patients with mild persistent asthma due to grass pollen.
    Marogna M; Spadolini I; Massolo A; Berra D; Zanon P; Chiodini E; Canonica GW; Passalacqua G
    Ann Allergy Asthma Immunol; 2009 Jan; 102(1):69-75. PubMed ID: 19205289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized open comparison of montelukast and sublingual immunotherapy as add-on treatment in moderate persistent asthma due to birch pollen.
    Marogna M; Colombo F; Spadolini I; Massolo A; Berra D; Zanon P; Chiodini E; Canonica GW; Passalacqua G
    J Investig Allergol Clin Immunol; 2010; 20(2):146-52. PubMed ID: 20461969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adherence to allergen immunotherapy improves when patients choose the route of administration: Subcutaneous or sublingual.
    Sánchez J
    Allergol Immunopathol (Madr); 2015; 43(5):436-41. PubMed ID: 25201758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specific sublingual immunotherapy in atopic dermatitis. Results of a 6-year follow-up of 35 consecutive patients.
    Mastrandrea F; Serio G; Minelli M; Minardi A; Scarcia G; Coradduzza G; Parmiani S
    Allergol Immunopathol (Madr); 2000; 28(2):54-62. PubMed ID: 10804094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of subcutaneous and sublingual immunotherapy with grass allergens for seasonal allergic rhinitis: a meta-analysis-based comparison.
    Di Bona D; Plaia A; Leto-Barone MS; La Piana S; Di Lorenzo G
    J Allergy Clin Immunol; 2012 Nov; 130(5):1097-1107.e2. PubMed ID: 23021885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medication persistence with long-term, specific grass pollen immunotherapy measured by prescription renewal rates.
    Sieber J; De Geest S; Shah-Hosseini K; Mösges R
    Curr Med Res Opin; 2011 Apr; 27(4):855-61. PubMed ID: 21323505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of sublingual swallow immunotherapy in children with rye grass pollen allergic rhinitis: a double-blind placebo-controlled study.
    Ahmadiafshar A; Maarefvand M; Taymourzade B; Mazloomzadeh S; Torabi Z
    Iran J Allergy Asthma Immunol; 2012 Jun; 11(2):175-81. PubMed ID: 22761191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [ANALYSIS OF BACKGROUNDS AND LEVEL OF UNDERSTANDING OF TREATMENT OF POOR ADHERENCE AND DROPOUT CASES ON SUBLINGUAL IMMUNOTHERAPY FOR JAPANESE CEDAR POLLINOSIS IN THE FIRST FOLLOW-UP YEAR].
    Kikkawa S; Kamijo A; Nakagome K; Soma T; Kobayashi T; Uchida Y; Morita E; Nagata M; Inoue T; Kase Y
    Arerugi; 2017; 66(9):1165-1171. PubMed ID: 29129887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized controlled trial of high-dose sublingual immunotherapy to treat seasonal allergic rhinitis.
    Smith H; White P; Annila I; Poole J; Andre C; Frew A
    J Allergy Clin Immunol; 2004 Oct; 114(4):831-7. PubMed ID: 15480323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subcutaneous versus sublingual immunotherapy for allergic rhinitis and/or asthma.
    Bahceciler NN; Cobanoglu N
    Immunotherapy; 2011 Jun; 3(6):747-56. PubMed ID: 21668312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of sublingual immunotherapy efficacy in children with house dust mite-induced allergic asthma optimally controlled by pharmacologic treatment and mite-avoidance measures.
    Pham-Thi N; Scheinmann P; Fadel R; Combebias A; Andre C
    Pediatr Allergy Immunol; 2007 Feb; 18(1):47-57. PubMed ID: 17295799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost effectiveness of sublingual immunotherapy in children with allergic rhinitis and asthma.
    Berto P; Bassi M; Incorvaia C; Frati F; Puccinelli P; Giaquinto C; Cantarutti L; Ortolani C
    Eur Ann Allergy Clin Immunol; 2005 Oct; 37(8):303-8. PubMed ID: 17066648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sublingual immunotherapy in youngsters: adherence in a randomized clinical trial.
    Röder E; Berger MY; de Groot H; Gerth van Wijk R
    Clin Exp Allergy; 2008 Oct; 38(10):1659-67. PubMed ID: 18631346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Efficacy and safety of sublingual immunotherapy with house dust mite extract in poly allergen sensitized children with allergic rhinitis].
    Zhou L; Wang J; Chen Y; Luo R; Tao J; Nie M; Liu B; Li Y
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Oct; 26(20):913-6. PubMed ID: 23272490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transient impact of omalizumab in pollen allergic patients undergoing specific immunotherapy.
    Kopp MV; Hamelmann E; Bendiks M; Zielen S; Kamin W; Bergmann KC; Klein C; Wahn U;
    Pediatr Allergy Immunol; 2013 Aug; 24(5):427-33. PubMed ID: 23799935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of sublingual immunotherapy with grass monomeric allergoid: comparison between two different treatment regimens.
    Quercia O; Bruno ME; Compalati E; Falagiani P; Mistrello G; Stefanini GF
    Eur Ann Allergy Clin Immunol; 2011 Dec; 43(6):176-83. PubMed ID: 22360134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of long-term sublingual immunotherapy as an adjunct to pharmacotherapy in house dust mite-allergic children with asthma.
    Ozdemir C; Yazi D; Gocmen I; Yesil O; Aydogan M; Semic-Jusufagic A; Bahceciler NN; Barlan IB
    Pediatr Allergy Immunol; 2007 Sep; 18(6):508-15. PubMed ID: 17680909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative assessment of the compliance with once-daily sublingual immunotherapy in children (EASY project: evaluation of a novel SLIT formulation during a year).
    Passalacqua G; Musarra A; Pecora S; Amoroso S; Antonicelli L; Cadario G; Di Gioacchino M; Lombardi C; Ridolo E; Sacerdoti G; Schiavino D; Senna G
    Pediatr Allergy Immunol; 2007 Feb; 18(1):58-62. PubMed ID: 17295800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sublingual immunotherapy in children with allergic rhinoconjunctivitis mono-sensitized to house-dust-mites: a double-blind-placebo-controlled randomised trial.
    Aydogan M; Eifan AO; Keles S; Akkoc T; Nursoy MA; Bahceciler NN; Barlan IB
    Respir Med; 2013 Sep; 107(9):1322-9. PubMed ID: 23886432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.